Pituitary Dwarfism

Top drugs studied for this disease

EMA approval · 2025-08-05
EMA Authorised: Omnitrope (somatropin) — Sandoz GmbH
The European Medicines Agency authorised Omnitrope (somatropin) by Sandoz GmbH for the treatment of Turner syndrome, Prader-Willi syndrome, …
EMA approval · 2023-07-20
EMA Authorised: NutropinAq (somatropin) — Ipsen Pharma
EMA authorised NutropinAq (somatropin) for Turner syndrome and pituitary dwarfism, with Ipsen Pharma as MAH.